Blog
Metro Bank plc: Publication of Annual Report and Accounts and Notice of 2023 Annual General Meeting
Metro Bank plc: Publication of Annual Report and Accounts and Notice of 2023 Annual General Meeting
Hardman & Co Research on Oakley Capital Investments Ltd (OCI): 2022: NAV returns driven by EBITDA growth
Hardman & Co Research on Oakley Capital Investments Ltd (OCI): 2022: NAV returns driven by EBITDA growth
EQS-News: Mainz Biomed Announces Partnership with Labor Staber to Expand ColoAlert Commercialization in Germany
EQS-News: Mainz Biomed Announces Partnership with Labor Staber to Expand ColoAlert Commercialization in Germany
Directorate change
Directorate change
Director/PDMR Shareholding
Director/PDMR Shareholding
EQS-News: KAP ACHIEVES SIGNIFICANT INCREASE IN REVENUE IN THE 2022 FINANCIAL YEAR
EQS-News: KAP ACHIEVES SIGNIFICANT INCREASE IN REVENUE IN THE 2022 FINANCIAL YEAR
Notice of 2022 Full Year Results and Investor Presentations
Notice of 2022 Full Year Results and Investor Presentations
Cairn Homes Plc: Transaction in Own Shares
Cairn Homes Plc: Transaction in Own Shares
EQS-News: GLOBAL FASHION GROUP REPORTS Q4 AND FY 2022 RESULTS
EQS-News: GLOBAL FASHION GROUP REPORTS Q4 AND FY 2022 RESULTS
EQS-News: Smartbroker Holding AG: Preliminary financial results for the full year 2022 - second-best performance in the Company's history despite challenging market environment
EQS-News: Smartbroker Holding AG: Preliminary financial results for the full year 2022 - second-best performance in the Company's history despite challenging market environment
EQS-News: PharmaSGP confirms record revenue and record profitability for 2022 and publishes forecast for 2023
EQS-News: PharmaSGP confirms record revenue and record profitability for 2022 and publishes forecast for 2023
Cembra publishes agenda items for the Annual General Meeting 2023 and its Annual Report 2022
Cembra publishes agenda items for the Annual General Meeting 2023 and its Annual Report 2022
Kuros Biosciences reports results for the full year 2022
Kuros Biosciences reports results for the full year 2022
Relief Therapeutics Provides Update From Collaboration Partner on OLPRUVA™
Relief Therapeutics Provides Update From Collaboration Partner on OLPRUVA™
EQS-News: E.ON SE: E.ON plans to increase investments in the energy transition following good full-year results
EQS-News: E.ON SE: E.ON plans to increase investments in the energy transition following good full-year results
EQS-News: Lucinda Crabtree to Join MorphoSys as Chief Financial Officer
EQS-News: Lucinda Crabtree to Join MorphoSys as Chief Financial Officer
EQS-Adhoc: PharmaSGP Holding SE releases forecast for full year 2023
EQS-Adhoc: PharmaSGP Holding SE releases forecast for full year 2023
Rights and Issues Investment Trust PLC: POS-Transaction in Own Shares
Rights and Issues Investment Trust PLC: POS-Transaction in Own Shares
EQS-News: Fabasoft AG: Fabasoft submits to the German Corporate Governance Code
EQS-News: Fabasoft AG: Fabasoft submits to the German Corporate Governance Code
EQS-News: Steinhoff International Holdings N.V. : Annual General Meeting and Update on LSW Settlement
EQS-News: Steinhoff International Holdings N.V. : Annual General Meeting and Update on LSW Settlement
EQS-Adhoc: Smartbroker Holding AG publishes forecast for the full year 2023
EQS-Adhoc: Smartbroker Holding AG publishes forecast for the full year 2023
EQS-News: Pfeiffer Vacuum Technology AG: Pfeiffer Vacuum Technology AG is Entering into a Domination and Profit and Loss Transfer Agreement with Pangea GmbH
EQS-News: Pfeiffer Vacuum Technology AG: Pfeiffer Vacuum Technology AG is Entering into a Domination and Profit and Loss Transfer Agreement with Pangea GmbH
EQS-Adhoc: Pfeiffer Vacuum Technology AG: Domination and Profit and Loss Transfer Agreement Pursuant to Sections 291 et seqq. AktG Concluded between Pfeiffer Vacuum Technology AG and Pangea GmbH
EQS-Adhoc: Pfeiffer Vacuum Technology AG: Domination and Profit and Loss Transfer Agreement Pursuant to Sections 291 et seqq. AktG Concluded between Pfeiffer Vacuum Technology AG and Pangea GmbH
Hardman & Co Research on Apax Global Alpha (APAX): Outperformance by adding value to companies
Hardman & Co Research on Apax Global Alpha (APAX): Outperformance by adding value to companies
EQS-Adhoc: K+S Aktiengesellschaft: K+S resolves to return capital to shareholders of up to a total of EUR 391.4 million or about EUR 2 per share (Vara consensus estimate: EUR 1.50 per share)
EQS-Adhoc: K+S Aktiengesellschaft: K+S resolves to return capital to shareholders of up to a total of EUR 391.4 million or about EUR 2 per share (Vara consensus estimate: EUR 1.50 per share)


